Regulatory Ready Scanadu is pursuing FDA clearance for all products, which can unlock hospital, clinic, and telehealth sales channels that require clinically validated devices.

Maternal Health The urine test kit targets gestational diabetes and prenatal health markers, creating opportunities to partner with obstetrics clinics, maternity programs, and pharmacies, with potential cross selling alongside the Scout device for integrated maternal monitoring.

Data Driven A long term plan to fuse sensors with intelligent algorithms enables software licensing deals with providers, care management programs and payers for remote monitoring and personalized care.

Scale Partnerships Being a small, venture backed company, Scanadu can accelerate distribution and scale via partnerships with larger medtech manufacturers, distributors and contract manufacturers for co development and market entry.

Market Momentum Past consumer funding and prize recognition indicate strong market interest; leverage DTC campaigns and telehealth ecosystem integrations to drive pilot programs and early adopters.